Recent developments in inflammatory bowel disease
- 1 November 2002
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 86 (6) , 1497-1523
- https://doi.org/10.1016/s0025-7125(02)00085-8
Abstract
No abstract availableKeywords
This publication has 159 references indexed in Scilit:
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's diseaseGut, 1998
- Oral budesonide as maintenance therapy in Crohn’s disease—results of a 12‐month studyAlimentary Pharmacology & Therapeutics, 1998
- Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.Gut, 1996
- Efficacy of cyclosporine in treatment of fistula of crohn's diseaseDigestive Diseases and Sciences, 1994
- Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's diseaseDigestive Diseases and Sciences, 1992
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Favorable effect of 6-Mercaptopurine on fistulae of Crohn's diseaseDigestive Diseases and Sciences, 1985
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980
- A controlled trial of azathioprine in Crohn's diseaseDigestive Diseases and Sciences, 1975